Harpoon Therapeutics Overview

  • Year Founded
  • 2015

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 55

Employees

  • Latest Deal Type
  • M&A

  • Financing Rounds
  • 8

Harpoon Therapeutics General Information

Description

Harpoon Therapeutics Inc is a clinical-stage immunotherapy company. It is engaged in developing a novel class of T cell engagers that harness the power of the body's immune system to treat patients suffering from cancer and other diseases. The company's pipeline products include HPN424, HPN536, HPN217, and others.

Contact Information

Ownership Status
Acquired/Merged
(Operating Subsidiary)
Financing Status
Corporate Backed or Acquired
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Parent Company
Former Stock Listing
HARP
Corporate Office
  • 611 Gateway Boulevard
  • Suite 400
  • South San Francisco, CA 94080
  • United States
+1 (650) 000-0000

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Harpoon Therapeutics Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Harpoon Therapeutics‘s full profile, request access.

Request a free trial

Harpoon Therapeutics Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Harpoon Therapeutics Inc is a clinical-stage immunotherapy company. It is engaged in developing a novel class of T cell
Drug Discovery
South San Francisco, CA
55 As of 2024
00000
00000 0000-00-00
000000&0 00000

000000

o laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in repr
0000000000000
Dallas, TX
00 As of 0000
00000
0000000000 00000

000000

ua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut a
0000000000000
San Carlos, CA
000 As of 0000
00000
00000000 00000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Harpoon Therapeutics Competitors (97)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Instil Bio Formerly VC-backed Dallas, TX 00 00000 0000000000 00000
Iovance Biotherapeutics Corporation San Carlos, CA 000 00000 00000000 00000
Inovio Pharmaceuticals Corporation Plymouth Meeting, PA 000 000.00 00000000 000.00
Aileron Therapeutics Formerly VC-backed Watertown, MA 0 00000 000000000 00000
Vertex Pharmaceuticals Formerly VC-backed Boston, MA 0000 00.000 000000&0
You’re viewing 5 of 97 competitors. Get the full list »

Harpoon Therapeutics Patents

Harpoon Therapeutics Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
AU-2022297538-A1 Extended-release immune cell engaging proteins and methods of treatment Pending 25-Jun-2021 000000000
CA-3224137-A1 Extended-release immune cell engaging proteins and methods of treatment Pending 25-Jun-2021 000000000
EP-4359443-A2 Extended-release immune cell engaging proteins and methods of treatment Pending 25-Jun-2021 000000000
US-20240216518-A1 Extended-release immune cell engaging proteins and methods of treatment Pending 25-Jun-2021 000000000
AU-2022286407-A1 Dll3 targeting trispecific proteins and methods of use Pending 03-Jun-2021 C07K16/28
To view Harpoon Therapeutics’s complete patent history, request access »

Harpoon Therapeutics Executive Team (13)

Name Title Board Seat
Frank Lanza Chief Financial Officer & Controller
Wendy Chang Chief People Officer
Holger Wesche Chief Scientific Officer
Luke Walker MD Chief Medical Officer
James Bucher JD Chief Legal Officer
You’re viewing 5 of 13 executive team members. Get the full list »

Harpoon Therapeutics Board Members (15)

Name Representing Role Since
000000 0000000 Self Board Member 000 0000
00 00000 00.0 Self Board Member 000 0000
00000000 00000000 Self Board Member 000 0000
000000 000000 Harpoon Therapeutics Board Member 000 0000
0000 0000 Arix Bioscience Board Member 000 0000
You’re viewing 5 of 15 board members. Get the full list »

Harpoon Therapeutics Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Harpoon Therapeutics Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Harpoon Therapeutics‘s full profile, request access.

Request a free trial

Harpoon Therapeutics ESG

Risk Overview

Risk Rating

Updated April, 01, 2022

35.56 | High Risk

Risk Scale

A lower score indicates better sustainability

Negl

0-10

Low

10-20

Med

20-30

High

30-40

Severe

40+

Exposure

Exposure refers to the extent to which a company is exposed to different material ESG issues

00.00

Management

Management is related to actions taken to manage ESG issues

00.00

Peers Analysis

Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.

Global

Covered Companies

00 of 14,912

Rank

00.00

Percentile

Pharmaceuticals

Industry

00 of 965

Rank

00.00

Percentile

Biotechnology

Subindustry

00 of 443

Rank

00.00

Percentile

To view Harpoon Therapeutics’s complete esg history, request access »

Harpoon Therapeutics FAQs

  • When was Harpoon Therapeutics founded?

    Harpoon Therapeutics was founded in 2015.

  • Where is Harpoon Therapeutics headquartered?

    Harpoon Therapeutics is headquartered in South San Francisco, CA.

  • What is the size of Harpoon Therapeutics?

    Harpoon Therapeutics has 55 total employees.

  • What industry is Harpoon Therapeutics in?

    Harpoon Therapeutics’s primary industry is Drug Discovery.

  • Is Harpoon Therapeutics a private or public company?

    Harpoon Therapeutics is a Private company.

  • What is the current valuation of Harpoon Therapeutics?

    The current valuation of Harpoon Therapeutics is 00000.

  • What is Harpoon Therapeutics’s current revenue?

    The current revenue for Harpoon Therapeutics is 000000.

  • How much funding has Harpoon Therapeutics raised over time?

    Harpoon Therapeutics has raised $446M.

  • Who are Harpoon Therapeutics’s investors?

    Ally Bridge Group, Arix Bioscience, Commodore Capital, Cormorant Asset Management, and K2 HealthVentures are 5 of 18 investors who have invested in Harpoon Therapeutics.

  • Who are Harpoon Therapeutics’s competitors?

    Instil Bio, Iovance Biotherapeutics, Inovio Pharmaceuticals, Aileron Therapeutics, and Vertex Pharmaceuticals are some of the 97 competitors of Harpoon Therapeutics.

  • When was Harpoon Therapeutics acquired?

    Harpoon Therapeutics was acquired on 11-Mar-2024.

  • Who acquired Harpoon Therapeutics?

    Harpoon Therapeutics was acquired by Merck & Co..

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »